| Date Filed | Type | Description |
| 06/24/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 06/24/2020 |
GN
| Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase |
| 06/12/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 06/09/2020 |
GN
| Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals |
| 04/20/2020 |
S-3DPOS
| Form S-3DPOS - Post-effective amendments, registration of securities, dividend or interest reinvestment plans, immediately effective: |
| 04/20/2020 |
S-3DPOS
| Form S-3DPOS - Post-effective amendments, registration of securities, dividend or interest reinvestment plans, immediately effective: |
| 04/20/2020 |
S-3DPOS
| Form S-3DPOS - Post-effective amendments, registration of securities, dividend or interest reinvestment plans, immediately effective: |
| 04/20/2020 |
S-3DPOS
| Form S-3DPOS - Post-effective amendments, registration of securities, dividend or interest reinvestment plans, immediately effective: |
| 04/20/2020 |
S-3DPOS
| Form S-3DPOS - Post-effective amendments, registration of securities, dividend or interest reinvestment plans, immediately effective: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/20/2020 |
8-K
| Bankruptcy or Receivership, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Ch... |
| 04/14/2020 |
8-K
| Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/04/2020 |
GN
| Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company |
| 02/14/2020 |
8-K
| Quarterly results |
| 02/13/2020 |
GN
| Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures |
| 02/05/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/08/2020 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 12/27/2019 |
8-K
| Quarterly results |
| 12/27/2019 |
GN
| Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility |
| 11/12/2019 |
GN
| Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019 |
| 11/12/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 11/06/2019 |
8-K
| Other Events |
| 10/25/2019 |
3
| Lococo Ryan (COO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 10/25/2019 |
3
| Blum Susan (VP of Finance & CAO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 10/24/2019 |
8-K
| Quarterly results |
| 09/13/2019 |
3
| Sanfilippo Jennifer A (interim Chief Executive Office) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
|